Obermatt

Treatt

LSE:TET · GB00BKS7YK08
ChemicalsSmall

360

32
EV / EBIT24
Price / Owner Earnings17
Owner Earnings Yield52
Dividend Yield47
Price/Sales43
EV / Gross Profit37
Price/Book60
Return on Capital60
Cash Return on Capital53
Return on Equity42
EBIT Margin59
Gross Profitability59
Cash Conversion44
Accruals37
Owner Earnings Margin50
Sales growth44
Profit Growth19
Long-Term EPS Growth4
Owner Earnings Growth40
Reinvestment64
Price momentum67
Debt load93
Refinancing80
Debt Payback44
Liquidity87
Analyst ratings49
Opinion Changes13
Price Target Upside5
Market mood39
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Treatt doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUK
IndustryChemicals
SizeSmall
TypePublic Company
ExchangeLSE
Founded1981
Employees219
Websitetreatt.com
ISINGB00BKS7YK08
Last UpdateApr 2, 2026
Themes
CoffeeNutraceuticalLifestyleFast-Moving Consumer GoodsChemical

Description

Treatt plc, together with its subsidiaries, manufactures and supplies various natural extracts and ingredients to the flavor, fragrance, beverage, and consumer product industries in the United Kingdom, Germany, Ireland, the United States, China, and…

Analysis

Middle-of-the-road

Treatt plc sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 33.6×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 13% a year, against analyst forecasts of -13%. The market is pricing in far more than analysts expect: heroic expectations.

Growth is tepid; the safety picture is sturdy. The company scores 6/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
65
2023202420252026

All-time high

90

Jan 2024

All-time low

43

Jan 2023

Average rank

72

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
43
26
23
13
Price/Earnings
16
49
29
5
Price/Book
60
49
36
12
Dividend Yield
47
48
34
32
Value (overall)
32
30
21
5

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Treatt with its peers
Givaudan
VTX:GIVN
45
CountrySwitzerland
IndustryChemicals
SizeSmall
Full Stock Analysis →
Robertet
PAR:RBT
55
CountryFrance
IndustryChemicals
SizeMedium
Full Stock Analysis →
Kri Kri
ATH:KRI
80
CountryGreece
IndustryFood Products
SizeSmall
Full Stock Analysis →
Symrise
GER:SY1
27
CountryGermany
IndustryChemicals
SizeLarge
Full Stock Analysis →
G Willi Food
NAQ:WILC
67
CountryIsrael
IndustryFood & Staples Retailing
SizeSmall
Full Stock Analysis →
Solvay
BRU:SOLB
14
CountryBelgium
IndustryChemicals
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →